Dividends
publishIn addition to the Dividend P/S, our screener highlights companies that excel in delivering consistent and attractive returns to shareholders. By focusing on this metric, you can quickly identify companies that balance dividend payouts with strong sales figures, ensuring sustainable dividends for the long term.
| name | arrow_downwardDividends P/S (FY) | Price | $ Change | % Change | Dividends P/S (FQ) | Payout Ratio % (TTM) | Dividends P/S Growth % | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|
IVCBInvestcorp Europe Acquisition Corp I | _ | $11.78 | -$0.02 | arrow_drop_down0.16% | _ | - | - | AI Analysis | |||
TUSKMammoth Energy Services | _ | $4.10 | $0.09 | arrow_drop_up2.36% | $0.12 | - | - | AI Analysis | |||
LEXXLexaria Bioscience | _ | $3.02 | $0.05 | arrow_drop_up1.68% | _ | - | - | AI Analysis | |||
TACTTransAct Technologies | _ | $4.76 | $0.06 | arrow_drop_up1.27% | $0.09 | - | - | AI Analysis | |||
BCTX BCTXWBriaCell Therapeutics | _ | $0.32 | $0.03 | arrow_drop_up10.00% | _ | - | - | AI Analysis | |||
HOFV HOFVHall of Fame Resort & Entertainment Company | _ | $1.94 | $0.08 | arrow_drop_up4.30% | _ | - | - | AI Analysis | |||
SENEASeneca Foods | _ | $62.99 | $0.00 | 0.00% | _ | - | - | AI Analysis | |||
TGAAWTarget Global Acquisition I | _ | $0.07 | -$0.01 | arrow_drop_down17.63% | _ | - | - | AI Analysis | |||
ELYMEliem Therapeutics | _ | $4.98 | -$0.02 | arrow_drop_down0.40% | _ | - | - | AI Analysis | |||
 CBRECBRE Group | _ | $123.17 | -$0.31 | arrow_drop_down0.25% | _ | - | - | AI Analysis | |||
OLKOlink Holding AB | _ | $26.08 | $0.00 | 0.00% | _ | - | - | AI Analysis | |||
REZIResideo Technologies | _ | $20.03 | $0.34 | arrow_drop_up1.72% | _ | - | - | AI Analysis | |||
LODEComstock Mining | _ | $0.49 | -$0.13 | arrow_drop_down20.96% | _ | - | - | AI Analysis | |||
LVTXLava Therapeutics B.V. | _ | $1.67 | $0.02 | arrow_drop_up1.69% | _ | - | - | AI Analysis | |||
TPET TPETTrio Petroleum Corp. Common Stock | _ | $0.16 | -$0.00 | arrow_drop_down0.59% | _ | - | - | AI Analysis | |||
VERVVerve Therapeutics | _ | $4.98 | $0.02 | arrow_drop_up0.40% | _ | - | - | AI Analysis | |||
CYRXCryoPort | _ | $8.00 | $0.03 | arrow_drop_up0.37% | _ | - | - | AI Analysis | |||
MXCTMaxCyte | _ | $3.87 | -$0.02 | arrow_drop_down0.51% | _ | - | - | AI Analysis | |||
SIXSix Flags Entertainment | _ | $0.05 | $0.00 | 0.00% | _ | - | - | AI Analysis | |||
TTITETRA Technologies | _ | $2.90 | $0.05 | arrow_drop_up1.75% | $0.10 | - | - | AI Analysis |
Showing 3161-3180 of 4976
Results per page:
If dividends are a key part of your investment strategy, the Stocklytics Dividends Screener is here to help. We rank stocks by dividend price-to-sales ratio (P/S) for the fiscal year (FY) in descending order, giving you access to the most rewarding dividend-paying stocks.
In addition to the Dividend P/S, our screener highlights companies that excel in delivering consistent and attractive returns to shareholders. By focusing on this metric, you can quickly identify companies that balance dividend payouts with strong sales figures, ensuring sustainable dividends for the long term.
Why Focus on Dividend P/S (FY)?
- Maximize Dividend Returns: Stocks with a high Dividend P/S ratio offer investors substantial dividends relative to their sales, an excellent indicator of potential returns.
- Sustainability: A balanced Dividend P/S ratio points to companies that can sustain their dividend payouts without jeopardizing future growth.
- Whether you’re looking for high-yield dividend stocks or companies with stable dividend histories, the
Stocklytics Dividends Screener gives you the insights you need to focus on the most promising opportunities for dividend income.
Discover the Power of Stocklytics Tools
Our suite of tools empowers you to make informed decisions, seize opportunities, and stay ahead in the competitive trading world.
See Stocklytics Tools